Abstract
Heart failure (HF), a heterogeneous syndrome of epidemic proportions, is increasingly defined by its underlying molecular and genomic alterations. Molecular cardiac imaging has emerged as a complementary discipline that has improved the understanding of the pathophysiologic principles governing experimental HF and has a potential to revolutionize assessment and management of HF in humans.
MeSH terms
-
3-Iodobenzylguanidine
-
Adenoviridae / genetics
-
Genes, Reporter
-
Genetic Vectors
-
Green Fluorescent Proteins / metabolism
-
Heart Failure / physiopathology
-
Humans
-
Luciferases / metabolism
-
Positron-Emission Tomography*
-
Radiopharmaceuticals*
-
beta-Galactosidase / metabolism
Substances
-
Radiopharmaceuticals
-
Green Fluorescent Proteins
-
3-Iodobenzylguanidine
-
Luciferases
-
beta-Galactosidase